Conference abstract · 23 Oct 2019
Conference abstractPublished 24 Nov 2017
Helicobacter pylori infection: Pathogenesis and therapeutic strategies
Sapienza University of Rome, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction & Aim: Helicobacter pylori (Hp) are gram-negative mobile bacilli, difficult to be cultured, and able to cause different diseases. In fact, Hp is involved in chronic active gastritis, peptic ulcer disease, gastric carcinoma and mucosa-associated lymphoid tissue lymphoma (MALT) other than in endothelial dysfunction leading to vascular diseases. Hp is increasingly difficult to treat. The treatment regimens are declining in efficacy and the therapy of this infection is bedevilled by drug-resistant strains. Aim of our research is to study a population of 50 pangastritis already undergone multiple therapies and to evaluate the eradication rates. Methods: All patients were positive to UBT (Urease Breath Test) then surely infected by Hp. Three biopsies were taken for each patient and submitted to rapid urease test, culture and antibiotics susceptibility by E-test. Results: Out of 50 patients, culture and susceptibility testing were obtained in 31 patients (62%) whereas in 19 (38%) no H. pylori growth was detected. The first group was treated following the scheme shown in the image whereas the second one was empirically treated with antibiotics never taken before or with rescue therapies. The eradication rates were 52% and 63%, respectively. Conclusions: No significant difference has been seen between the two groups. Probably the higher eradication rate in patients empirically treated, where no microorganisms have been isolated, can be due to the presence of bacteria not able to grow in culture then in a less virulent or dormant phase or in a very low number to be detected. Anyway, in our study the eradication rates of these pangastritis patients undergone multiple treatments are very low. The Toronto Consensus Group (2016) has proposed new treatment strategies recommending to prolong the cure from 10 to 14 days, to use bismuth quadruple therapy containing metronidazole and tetracycline as well as various rescue therapies.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 9 May 2018
Synergistic effects of combined curcumin and antibiotic in ameliorating an animal model of Helicobacter pylori infection
Research article · 2018
Helicobacter pylori Infection among Dyspeptic and Non-Dyspeptic HIV Patients at Yeka Health Center Addis Ababa, Ethiopia; Case Control Study
Research article · 31 Mar 2017
Prevalence and Risk Factors of Helicobacter pylori Infection in Muong Children in Vietnam
Review article · 2017
Serological Biomarker Panel (GastroPanel®): A Test for Non-Invasive Diagnosis of Dyspeptic Symptoms and for Comprehensive Detection of Helicobacter pylori Infection
More from this journal
The newest in Journal of Clinical & Experimental Pathology.
Research article · 24 Feb 2025
Combining Urinary Biomarker Panels and Machine Learning For Earlier Detection of Pancreatic Cancer
Research article · 3 Feb 2025
Outbreak of Crimean Congo Haemorrhagic Fever in Northern Senegal in 2022
Review article · 16 Jan 2025
Recent Updates on Huntington Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Pathology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Maria Teresa Mascellino”
